SCHEMBL2225574

SCHEMBL2225574

NS(=O)(=O)c1ccc(OC(F)(F)F)c(CNc2cc(Nc3ccc(Cl)cc3)ncn2)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 12/20 0.59
ABL1 P00519 2/20 0.51
BCR P11274 2/20 0.51
CDK1 P06493 1/20 0.47
CCNB1 P14635 1/20 0.47
CCNA2 P20248 1/20 0.47
CCNE1 P24864 1/20 0.47
CDK2 P24941 1/20 0.47
CDK5 Q00535 1/20 0.47
CDK5R1 Q15078 1/20 0.47
EGFR P00533 2/20 0.46
ERBB3 P21860 2/20 0.46
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
STAT3 P40763 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2228424 0.90 TNNI3K (0.61) TNNI3KABL1BCRCDK1CCNB1
SCHEMBL2225100 0.90 ABL1 (0.48) TNNI3KABL1BCRCDK1CCNB1
SCHEMBL2227178 0.89 TNNI3K (0.61) TNNI3KABL1BCRCDK1CCNB1
SCHEMBL2224948 0.88 TNNI3K (0.51) TNNI3KABL1BCRCDK1CCNB1
SCHEMBL2227311 0.87 TNNI3K (0.61) TNNI3KCDK1CCNB1CCNA2CCNE1
SCHEMBL2226458 0.87 TNNI3K (0.49) TNNI3KABL1BCRCDK1CCNB1
SCHEMBL2226058 0.85 TNNI3K (0.49) TNNI3KCDK1CCNB1CCNA2CCNE1
SCHEMBL2226278 0.85 TNNI3K (0.52) TNNI3KCDK1CCNB1CCNA2CCNE1
SCHEMBL2228373 0.84 TNNI3K (0.48) TNNI3KCDK1CCNB1CCNA2CCNE1
Trifluoroacetic Acid SCHEMBL2226717 0.84 TNNI3K (0.47) TNNI3KABL1BCRCDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed